Certolizumab pegol for the treatment of patients with moderate-to-severe chronic plaque psoriasis: Pooled analysis of week 16 data from 3 randomized controlled trials
Journal of the European Academy of Dermatology and Venereology | Sep 28, 2018
Predictors of treatment success in children with difficult to treat atopic dermatitis using a personalized integrative multidisciplinary treatment program (PIM)
Journal of the European Academy of Dermatology and Venereology | Sep 16, 2018
Long-term safety profile of ixekizumab in patients with moderate-to-severe plaque psoriasis: An integrated analysis from 11 clinical trials
Journal of the European Academy of Dermatology and Venereology | Sep 15, 2018
Most read this week